A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)
Clinical trial NCT05144009 · TERMINATED
Trial details
- NCT number
- NCT05144009
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2024-01-22
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.